Juthathip Mongkolsapaya - Genetic Mutations

Author Information

Juthathip Mongkolsapaya is affiliated with multiple prestigious institutions: the Chinese Academy of Medical Science (CAMS) Oxford Institute (COI) at the University of Oxford, the Centre for Human Genetics, Nuffield Department of Medicine at the University of Oxford, and the Mahidol-Oxford Tropical Medicine Research Unit in Bangkok, Thailand. Her work primarily revolves around genetics and immunology, with a notable focus on viral infections such as SARS-CoV-2 and dengue.

Research Contributions

Juthathip Mongkolsapaya has made substantial contributions to understanding immune responses to viral infections. Her recent work in 2022 includes studies on the SARS-CoV-2 Omicron variant, neutralizing antibody responses, and the efficacy of different COVID-19 vaccines. She has also explored the immunogenicity of vaccines against various SARS-CoV-2 variants and the role of memory cytotoxic T cells in viral control. Additionally, her research extends to dengue virus, particularly examining factors like KIR copy number variations in infected patients and structural studies of viral proteins.

Aliases

Juthathip Mongkolsapaya is also known by the following aliases: J Mongkolsapaya, J. Mongkolsapaya, and Juthathip Mongkolsapaya.

Publication and Citation Metrics

Metric	Value
Total Citation Count	18,275
h-index	63
Total Number of Papers	186

Publications:

SARS-CoV-2 Omicron-B.1.1.529 leads to widespread escape from neutralizing antibody responses

DOI: 10.1016/j.cell.2021.12.046

Year: 2022

Neutralizing Activities against the Omicron Variant after a Heterologous Booster in Healthy Adults Receiving Two Doses of CoronaVac Vaccination.

DOI: 10.1093/infdis/jiac092

Year: 2022

Neutralizing Activities against the Omicron Variant after a Heterologous Booster in Healthy Adults Receiving Two Doses of CoronaVac Vaccination

DOI: 10.1101/2022.01.28.22269986

Year: 2022

Memory cytotoxic SARS-CoV-2 spike protein-specific CD4+ T cells associate with viral control

DOI: 10.21203/rs.3.rs-1317569/v1

Year: 2022

Comparison of the reactogenicity and immunogenicity of a reduced and standard booster dose of the mRNA COVID-19 vaccine in healthy adults after two doses of inactivated vaccine.

DOI: 10.1101/2022.03.01.22271735

Year: 2022

Heterologous versus homologous COVID-19 booster vaccination in previous recipients of two doses of CoronaVac COVID-19 vaccine in Brazil (RHH-001): a phase 4, non-inferiority, single blind, randomised study

DOI: 10.1016/S0140-6736(22)00094-0

Year: 2022

KIR copy number variations in dengue-infected patients from northeastern Thailand.

DOI: 10.1016/j.humimm.2022.01.005

Year: 2022

The ChAdOx1 vectored vaccine, AZD2816, induces strong immunogenicity against SARS-CoV-2 beta (B.1.351) and other variants of concern in preclinical studies

DOI: 10.1016/j.ebiom.2022.103902

Year: 2022

CryoEM structures of the multimeric secreted NS1, a major factor for dengue hemorrhagic fever

DOI: 10.1101/2022.04.04.487075

Year: 2022

The antibody response to SARS-CoV-2 Beta underscores the antigenic distance to other variants

DOI: 10.1016/j.chom.2021.11.013

Year: 2021

Who Should Consider Prenatal Screening and Genetic Counseling?

What Challenges Remain?

What are Biological Agents that Induce Mutations?

What is CRISPR Technology?

How Does Genetics Influence Occupational Therapy?

What is Hemoglobin S (HbS)?

What is the Role of Genetic Counseling in Sickle Cell Disease?

How Can Genetic Counseling Help?

How Do Genetic Mutations Affect Fertility?

What are the Effects of CNVs?

Partnered Content Networks

Relevant Topics